Companion Diagnostics: World Market Outlook 2011-2021

Our latest pharma report - Companion Diagnostics: World Market Outlook 2011-2021 - offers a comprehensive view of the global companion diagnostics market. The report analyses recent trends in this market and anticipates the progression in the market over the next decade with global, regional and submarket forecasts. The report also reveals the market's strengths and weaknesses revealing areas that will experience growth and present new business opportunities. Visiongain analyses predict the global value of the companion diagnostics market in 2011 to be worth $1.57bn. A number of specialty drugs will be associated with a companion diagnostic test by 2021, increasing the global market for companion diagnostics.

Companion diagnostics are diagnostic tests that are linked to a particular drug/therapy. This is a small, emerging market at present, but one of the fastest growing segments in the IVD market. The concept of a drug-diagnostic combination is not new, but has only started to garner interest, with the move of healthcare towards personalised medicine. Companion diagnostics combined with targeted therapeutics are the tools for providing personalised treatment. This market has significant potential for growth with the increasing demand for safer, efficacious drugs.

Visiongain's research suggests that the world companion diagnostics market will benefit from developments in biomarker discovery and use in early stages of drug development. These biomarkers for disease can be developed into companion diagnostics for clinical use. Also benefiting the companion diagnostics market will be efforts on the part of the regulatory authorities to develop clearer regulatory guidelines for the co-development of companion diagnostics.

The Companion Diagnostics: World Market Outlook 2011-2021 report examines the scope of growth available in the companion diagnostics industry given the increasing cost of drug development, rising cost of healthcare, and the need for medicines which do not have adverse drug reactions.

The companion diagnostics market is the fastest growing segment in the IVD market. Visiongain predicts that this market will grow steadily to 2021. The future of the companion diagnostics market appears promising, with increases in the demand for high priced specialist therapies and the demand for safer, more-efficacious drugs.

How will the companion diagnostic market develop this decade? Which regions offer the most significant growth opportunities between 2011 and 2021? Which of the companion diagnostic submarkets are growing most strongly? Who are the leading companies in the companion diagnostics market? Which regions offer the most significant companion diagnostics market growth opportunities between 2011 and 2021?

Visiongain answers these critical questions and many more through the in-depth analyses that are presented in this report.

Detailed analysis of the global Companion Diagnostics Market

Companion Diagnostics: World Market Outlook 2011-2021 examines that sector critically, through a comprehensive review of information sources, both primary and secondary. This report provides detailed sales forecasts, market share analyses, discussions of pipeline developments and analyses of commercial drivers and restraints, including a SWOT analysis. There are 50 tables and figures included, as well as two full interviews with relevant authorities. The result is a comprehensive market- and industry-centred study, with detailed analyses and informed opinion to benefit your work.

Why you should buy Companion Diagnostics: World Market Outlook 2011-2021

In this report, you will receive the following benefits in particular:

• You will receive our assessment of the current market for companion diagnostics
• You will discover sales trends for the overall companion diagnostics market from 2011 to 2021 - seeing where commercial growth will occur
• You will discover sales trends for the main segment - theranostics - from 2011 to 2021 - with detailed discussions of market potential
• You will receive sales forecasts for leading geographical markets (US, Japan, Germany, France, Italy, Spain, UK, China and India), with informed discussion
• You will assess leading companies in the companion diagnostics market, providing products and services in the market
• You will see a compiled list of some theranostic kits and lab tests that are currently available in the market, and drug-diagnostic combinations in development by pharmaceutical and diagnostic companies
• You will examine the emerging business models for the development of companion diagnostics
• You will be able to investigate competition and opportunities influencing the companion diagnostics market from 2011 onwards
• You will see what will stimulate and restrain the companion diagnostics market from 2011
• You will discover the unmet needs in the market, driving the growth from 2011 onwards
• You will view expert opinion from our survey, including full interview transcripts.

Please Note: Prior to initiating fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.

The publisher is using a password system to access all reports. This password will be set up for single user and departmental licenses and will be emailed out to the client at the same time as the report. In the case of departmental site license purchases, the publisher requires all email addresses for the licensed users prior to fulfillment.